Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

No live Event Card holds AARD yet. The best-performing live stock cards right now:

• SAIB: MRNA — Moderna +47.76% since launch (2026-09-06)
• SAIB: PTC — PTC Inc. +42.68% since launch (2026-09-15)
• SAIB: CRL — Charles River Laboratories +36.93% since launch (2026-09-15)
• SAIB: MTD — Mettler Toledo +32.10% since launch (2026-09-15)
• SAIB: RVTY — Revvity +29.26% since launch (2026-09-15)